Ensure Easy Access To Your Eversense App
Place the Eversense App on the home screen of your mobile device and be sure to keep the app open to easily access your glucose data.
Get Easy-To-Read Glucose Data With Your Eversense
Access your In-App Reports in the Eversense App to better understand your glucose patterns and history and learn how to easily share it with your health care provider.
Glucose Statistics Reports
Your Eversense CGM System automatically creates 4 reports which you can view at any time right in your app. Go to Reports and swipe right to see all four reports. These reports may help you and your health care provider fine tune your diabetes management plan.
Glucose Pie Chart Report
This report shows in graphical format what percent of your readings within a given time period are within, below, or above your Glucose Target levels.
Time in Range
This report shows the percentage of time spent in preset glucose ranges, based on the standardized AGP report guidelines.
Weekly Modal Summary
This report shows your last seven days of glucose readings summarized in a 24-hour line graph format to help find patterns during the day.
Glucose Statistics
This report shows your average, low, and high glucose readings, along with standard deviation within 6-hour time periods.
Helpful Tips
Access glucose data in the palm of your hand
Share Location When Prompted (Android Users Only)
The location services pop-up is for Android OS only and is needed for the initial pairing of the smart transmitter and the app only. Once the Bluetooth pairing is complete, data will transfer from the transmitter to the mobile app, and alerts will happen–even if you decide to turn off location services.
Discover more Tips & Tricks
Stay in the know with the Eversense E3 and get helpful pointers on how to manage your diabetes wi...
Learn how to set up and calibrate your system to start getting your glucose data and the most acc...
Find out how the Eversense E3 Smart Transmitter is designed to work the way you need and to be wo...
Trend Arrows And Treatment Decisions >
Stay on top of your diabetes management knowing you get exceptionally accurate1 readings, even wi...
Access your In-App Reports in the Eversense App to better understand your glucose patterns and hi...
Low And High Alerts, And Targets >
The Eversense E3 CGM System is designed to provide ON-BODY VIBRATION alerts through your smart tr...
Predictive And Rate of Change Alerts >
Even with the best management plan, diabetes can still be unpredictable at times. In addition to ...
Keep tabs on your glucose levels over time and share this information, to help you and your healt...
E3 Long Term Exceptional Accuracy >
There is no other CGM system available today to offer such exceptional accuracy with a single sen...
Taking care of family and friends, performing at work each day, challenging yourself with sports,...
When getting ready for traveling with diabetes, there is so much to think of, isn’t it? Of ...
Get Ready For Your Next E3 Sensor >
Preparing for your next sensor in advance will ensure a smooth and uninterrupted experience.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.